Leukemia treatment could get easier: shot may replace long IV drips
NCT ID NCT07223190
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 32 times
Summary
This study tests if a shot (subcutaneous injection) of the drug blinatumomab works as well as the standard IV drip for adults with a certain type of leukemia (Ph-negative B-ALL). About 560 newly diagnosed adults who are in remission after initial chemo will take part. The main goal is to see if the shot version helps people live just as long as the IV version.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHILADELPHIA CHROMOSOME NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.